

NCT00250640 Processed comparison:

Summary:
CHIA has 4 criteria while your personal folder has 7 criteria
Total found criteria: 3/4
Total not Found: 1/4
Total Extra: 3
This trial is INVALID



╒═══════════════════════════════════════════════════╤═══════════════════════════════════════════════════╕
│ CHIA Criteria                                     │ Matching Personal Criteria                        │
╞═══════════════════════════════════════════════════╪═══════════════════════════════════════════════════╡
│ The treating physician has chosen Ventavis as a   │ The treating physician has chosen Ventavis as a   │
│ suitable long-term treatment for the patient      │ suitable long-term treatment for the patient      │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┤
│ Patient with primary pulmonary hypertension (i e  │ Patient with primary pulmonary hypertension (i e  │
│ Idiopathic Pulmonary Arterial Hypertension or     │ Idiopathic Pulmonary Arterial Hypertension or     │
│ Familial Pulmonary Arterial Hypertension) and     │ Familial Pulmonary Arterial Hypertension) and     │
│ classified as NYHA functional class III (NYHA =   │ classified as NYHA functional class III (NYHA =   │
│ New York Heart Association)                       │ New York Heart Association)                       │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┤
│ No prior treatment with Ventavis or other active  │ No prior treatment with Ventavis or other active  │
│ treatments for primary pulmonary hypertension     │ treatments for primary pulmonary hypertension     │
│ within 6 weeks of date of study inclusion (unless │ within 6 weeks of date of study inclusion (unless │
│ otherwise advised by Bayer Schering Pharma)       │ otherwise advised by Bayer Schering Pharma)       │
╘═══════════════════════════════════════════════════╧═══════════════════════════════════════════════════╛



╒════════════════════════════════════════════════════════════════════════════════════════════════╕
│ CHIA Criteria Not Found in Personal                                                            │
╞════════════════════════════════════════════════════════════════════════════════════════════════╡
│ Any condition that prevents participation in the study including pregnancy and other           │
│ contraindications for Ventavis treatment (as listed in the current Ventavis Summary of Product │
│ Characteristics and patient package insert)                                                    │
╘════════════════════════════════════════════════════════════════════════════════════════════════╛



╒══════════════════════════════════════════════════════════════════════════════════════════════════════╕
│ Extra Personal Criteria                                                                              │
╞══════════════════════════════════════════════════════════════════════════════════════════════════════╡
│ Any condition that prevents participation in the study including pregnancy                           │
├──────────────────────────────────────────────────────────────────────────────────────────────────────┤
│ Must have minimum age of 18 Years                                                                    │
├──────────────────────────────────────────────────────────────────────────────────────────────────────┤
│ Other contraindications for Ventavis treatment (as listed in the current Ventavis Summary of Product │
│ Characteristics and patient package insert)                                                          │
╘══════════════════════════════════════════════════════════════════════════════════════════════════════╛